These results demonstrated the function of the lncRNA Xist/miR-19a-3p /Hoxa5 signaling pathway in aging-induced BMSCs osteogenic differentiation, revealing a potential therapeutic target for osteoporosis. This evidence concerns the gene HOXA5 and osteoporosis.